Pantilogos
Latest round
- Series A
Last raised
- Oct 2021
Total raised
- $11M
Investors
- 2
About Pantilogos
, is a biopharmaceutical company that develops anti-tumor cell and antibody therapeutics for the treatment of cancer and autoimmune diseases. The company is focused on the research and development of anti-tumor cell and antibody therapeutics aimed at treating cancer and autoimmune diseases. Leveraging advanced immunotherapy platforms, Pantilogos is working to develop novel biologics that target immune system pathways to enhance therapeutic efficacy and patient outcomes. Pantilogos’ product pipeline includes investigational therapies designed to modulate immune responses, with a focus on T-cell and antibody-based treatments. These therapies are intended to address unmet medical needs in oncology and immunology, offering potential alternatives to conventional treatments.
Who invested in Pantilogos
2 investors across 1 round
See all investors in Pantilogos
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 29, 2021
Amount
$11M
Investors
Questions about Pantilogos
Who invested in Pantilogos?
Pantilogos has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pantilogos raised?
Pantilogos has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Pantilogos last raise money?
Pantilogos's most recent round on record is a Series A, in Oct 2021.
What does Pantilogos do?
, is a biopharmaceutical company that develops anti-tumor cell and antibody therapeutics for the treatment of cancer and autoimmune diseases.
Where is Pantilogos headquartered?
Pantilogos is headquartered in Seoul, South Korea.
Which VCs invest in companies like Pantilogos?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Pantilogos's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Pantilogos? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.